Host: Scott Kopetz, MD, PhD Guest: Prof Eric Van Cutsem, MD, PhD Dr. Scott Kopetz and Prof. Eric Van Cutsem evaluate both the initial and updated pivotal outcomes from the BEACON trial in second- and third-line BRAF V600E-mutated metastatic colorec

Host: Pradeep Y. Ramulu, MD, PhD Guest: Ian Benjamin Gaddie, OD, FAAO Glaucoma is a major public health problem in the US with an estimated 3 million Americans diagnosed with the disease and as many as 120,000 who are blind as a result. Fortunately

Host: George Bakris, MD Guest: Matthew R. Weir, MD Guest: Faiez Zannad, MD, PhD The most common risk factors for hyperkalemia are reduced kidney function and treatment with renin-angiotensin-aldosterone system inhibitor (RAASi) therapy. With evid

Host: Sandra G. Adams, MD, MS, FCCP Guest: Sumita B. Khatri, MD, MS, FCCP Up to one-third of asthma cases may be misdiagnosed. Asthma symptoms overlap and can co-exist with other conditions, making it challenging to differentiate and confirm a seve

Host: Sandra G. Adams, MD, MS, FCCP Guest: Mario Castro, MD, MPH There's been an emergence of novel therapies for the treatment of severe asthma, including biologics targeting inflammatory pathways. These therapeutic options have ushered in a new e

Host: Sandra G. Adams, MD, MS, FCCP Guest: Anju T Peters, MD, MSCI, FAAAAI Selection among therapies for severe asthma can be challenging, but there are 'treatable traits' clinicians can use to better predict which patients will have a favorable re

Host: Richard T. Penson, MD, MRCP Guest: Linda R. Duska, MD, MPH There remains a critical unmet need for effective therapies following the recurrence of endometrial cancer. In this activity, Drs. Linda Duska and Richard Penson assess the role of im

Guest: Barbara Yawn, MD, MSc, FAAFP Host: John J. Russell, MD Severe asthma is linked to significant morbidity, health care resource utilization, and long-term sequelae including airway remodeling and a greater risk of developing chronic obstructiv

Host: Sandhya Khurana, MD, FCCP Guest: Monica Kraft, MD, FCCP Clinicians must be knowledgeable of the inflammatory, immunologic, and pathobiologic features leading to severe asthma. Clinicians must also have knowledge of severe asthma phenotypes an

Host: Sandhya Khurana, MD, FCCP Guest: Deepa Rastogi, MBBS, MS The presentation and management of pediatric asthma differs by age group and from adults. And since the management of uncontrolled asthma in children is especially challenging, pediatri